Opinion|Videos|August 1, 2024
A Case of IOL Exchange in a Patient Unhappy with their Previous Advanced Technology IOLs
Author(s)Kamran M. Riaz, MD
An ophthalmologist presents a case of a 75-year-old patient who was dissatisfied with previous intraocular lenses but achieved satisfactory vision with a monofocal plus IOL.
Advertisement
Advertisement
Related to this article
Bayer acquired Perfuse Therapeutics and its experimental endothelin-blocking eye implant PER-001, and partnered with AI firm Iambic Therapeutics to accelerate small molecule drug discovery.
Douglas D. Koch, MD, and Karolinne Maia Rocha, MD, PhD, discuss the optics behind enhanced monofocal lenses, patient selection, and how to set expectations.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: Optogenetic gene therapy heads to phase 2 trial in geographic atrophy
2
AAO 2026: DAYBREAK shows tarcocimab and tabirafusp-ted noninferior to aflibercept in wet AMD
3
Slowing Stargardt: What a 36% reduction in lesion growth could mean for adolescent patients
4
AAO 2026: Blood pressure and optic nerve perfusion: a complex relationship
5